Stryker entered a definitive agreement to acquire all issued and outstanding shares of Inari Medical's common stock. Stryker ...
Stryker announced that it has completed the acquisition of Inari Medical, Inc., a provider of solutions for venous thromboembo ...
We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...
The Portage, Michigan–based orthopedic and surgical device giant announced last month that it struck a deal to acquire Inari ...
Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of Inari ...
15d
Zacks.com on MSNReasons to Retain Inari Medical Stock in Your Portfolio for NowInari Medical, Inc. NARI is well-poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency on ...
and 280,000 pulmonary embolism (PE) patients eligible for these therapies, the addressable market is substantial. During the latest quarter, Inari’s global VTE business recorded a revenue ...
Background Physicians treating acute pulmonary embolism (PE) are faced with difficult management decisions while specific guidance from recent guidelines may be absent. Methods Fourteen clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results